查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1738276

乾眼症治療市場－全球產業規模、佔有率、趨勢、機會和預測，按適應症、產品類型、劑型、類型、配銷通路、地區和競爭情況分類，2020 年至 2030 年預測

Dry Eye Syndrome Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Indication, By Product Type, By Dosage Form, By Type, By Distribution Channel, By Region, and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球乾眼症治療市場價值為 63.1 億美元，預計到 2030 年將達到 91.5 億美元，預測期內的複合年成長率為 6.39%。這種成長是由於與類風濕性關節炎、狼瘡和甲狀腺疾病等自體免疫疾病相關的乾眼症盛行率不斷上升所致。越來越多的創新藥物療法和眼藥水配方獲得批准，加上乾眼症管理研發的進步，正在推動市場擴張。促進淚液分泌的鼻內淚液神經刺激裝置等技術進步也正在促進需求。此外，越來越多的新市場進入者湧入，加速了監管部門的批准並擴大了治療的可及性。然而，公眾意識有限和診斷不足仍然是市場滲透的重大障礙。

市場概覽
預測期 2026-2030
2024年市場規模 63.1億美元
2030年市場規模 91.5億美元
2025-2030 年複合年成長率 6.39%
成長最快的領域 水樣缺乏性乾眼症
最大的市場 北美洲

關鍵市場促進因素

老年人口成長及與年齡相關的眼部疾病

主要市場挑戰

患者認知度低和診斷不足

主要市場趨勢

人工智慧與診斷技術的融合

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：臨床試驗分析

第6章：全球乾眼症治療市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依適應症（蒸發過強型乾眼症、水樣液缺乏型乾眼症）
    • 依產品類型（環孢素、外用皮質類固醇、人工淚液、淚點塞、其他）
    • 按劑型（凝膠、眼藥水、膠囊及藥片、眼藥水、藥膏）
    • 依類型（處方藥、非處方藥）
    • 按配銷通路（醫院藥房、零售藥房、網路藥房）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖
    • 按適應症
    • 依產品類型
    • 按劑型
    • 按類型
    • 按配銷通路
    • 按地區

第7章：北美乾眼症治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第8章：歐洲乾眼症治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第9章：亞太乾眼症治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第10章：南美洲乾眼症治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 11 章：中東和非洲乾眼症治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 12 章：市場動態

  • 驅動程式
  • 挑戰

第13章：市場趨勢與發展

  • 最新動態
  • 併購
  • 產品發布

第 14 章：全球乾眼症治療市場：SWOT 分析

第 15 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品/服務的威脅

第 16 章：競爭格局

  • Johnson & Johnson Services, Inc.
  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Novartis AG
  • Sun Pharmaceuticals Industries Limited
  • Santen Pharmaceutical Co., Ltd.
  • Otsuka Pharmaceutical Co., Ltd.
  • Oyster Point Pharma, Inc.
  • Alcon Inc.
  • GlaxoSmithKline plc

第 17 章：策略建議

第18章調查會社について,免責事項

簡介目錄
Product Code: 14428

The Global Dry Eye Syndrome Treatment Market was valued at USD 6.31 billion in 2024 and is projected to reach USD 9.15 billion by 2030, growing at a CAGR of 6.39% during the forecast period. This growth is driven by the increasing prevalence of dry eye conditions linked to autoimmune diseases such as rheumatoid arthritis, lupus, and thyroid disorders. Rising approvals of innovative drug therapies and eye drop formulations, coupled with advancements in R&D for dry eye management, are propelling market expansion. Technological progress, such as intranasal tear neurostimulation devices that promote tear production, is also fostering demand. Additionally, a growing influx of new market entrants is accelerating regulatory approvals and broadening treatment accessibility. However, limited public awareness and underdiagnosis remain significant hurdles for market penetration.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 6.31 Billion
Market Size 2030USD 9.15 Billion
CAGR 2025-20306.39%
Fastest Growing SegmentAqueous Deficient Dry Eye Syndrome
Largest MarketNorth America

Key Market Drivers

Rising Geriatric Population and Age-Related Ocular Conditions

The expanding elderly demographic is a key driver for the global dry eye syndrome treatment market, as aging is closely linked to reduced tear production and gland function. Data from the United Nations Department of Economic and Social Affairs indicates that the global population aged 65 and over will exceed 1.6 billion by 2050. Older individuals are more susceptible to dry eye symptoms due to age-related degradation of tear film and meibomian gland health. In the United States, nearly 15% of adults over 50 report symptoms of dry eye, particularly among women. This demographic trend is creating sustained demand for targeted dry eye treatments, especially in developed regions where aging populations are most pronounced.

Key Market Challenges

Low Patient Awareness and Underdiagnosis

Despite its growing prevalence, dry eye syndrome remains significantly underdiagnosed due to limited public awareness and misconceptions about symptoms. Many individuals attribute discomfort to temporary factors and delay seeking professional care, leading to untreated cases. According to the U.S. National Eye Institute, a majority of dry eye sufferers remain undiagnosed, particularly in lower-income regions with limited access to specialized care. Additionally, inconsistent diagnostic standards and limited practitioner training contribute to misclassification and reliance on over-the-counter products. Cultural attitudes and the low prioritization of eye health in some countries further exacerbate this issue, restricting treatment adoption and hindering market growth.

Key Market Trends

Integration of Artificial Intelligence and Diagnostic Technologies

Artificial intelligence and advanced diagnostic tools are transforming how dry eye syndrome is detected and managed. AI-based imaging systems are increasingly used to assess tear stability, gland function, and ocular surface conditions with higher accuracy than manual observation. These tools are essential in streamlining diagnostics, particularly in teleophthalmology and high-volume clinical settings. Regulatory and funding support, such as the FDA's approval of AI diagnostic tools and the NIH's investments in healthcare AI, are accelerating adoption. Countries like Japan and South Korea are implementing AI within smart hospitals to enhance diagnostic efficiency. This technological integration supports early intervention, improves treatment outcomes, and lowers long-term healthcare expenditures related to untreated dry eye.

Key Market Players

  • Johnson & Johnson Services, Inc.
  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Novartis AG
  • Sun Pharmaceuticals Industries Limited
  • Santen Pharmaceutical Co., Ltd.
  • Otsuka Pharmaceutical Co., Ltd.
  • Oyster Point Pharma, Inc.
  • Alcon Inc.
  • GlaxoSmithKline plc

Report Scope:

In this report, the Global Dry Eye Syndrome Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dry Eye Syndrome Treatment Market, By Indication:

  • Evaporative Dry Eye Syndrome
  • Aqueous Deficient Dry Eye Syndrome

Dry Eye Syndrome Treatment Market, By Product Type:

  • Cyclosporine
  • Topical Corticosteroids
  • Artificial Tears
  • Punctal Plugs
  • Others

Dry Eye Syndrome Treatment Market, By Dosage Form:

  • Gels
  • Eye Solutions
  • Capsules & Tablets
  • Eye Drops
  • Ointments

Dry Eye Syndrome Treatment Market, By Type:

  • Prescription
  • Over The Counter

Dry Eye Syndrome Treatment Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Dry Eye Syndrome Treatment Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dry Eye Syndrome Treatment Market.

Available Customizations:

Global Dry Eye Syndrome Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Type
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Global Dry Eye Syndrome Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Indication (Evaporative Dry Eye Syndrome, Aqueous Deficient Dry Eye Syndrome)
    • 6.2.2. By Product Type (Cyclosporine, Topical Corticosteroids, Artificial Tears, Punctal Plugs, Others)
    • 6.2.3. By Dosage Form (Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments)
    • 6.2.4. By Type (Prescription, Over The Counter)
    • 6.2.5. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 6.2.6. By Region
    • 6.2.7. By Company (2024)
  • 6.3. Market Map
    • 6.3.1. By Indication
    • 6.3.2. By Product Type
    • 6.3.3. By Dosage Form
    • 6.3.4. By Type
    • 6.3.5. By Distribution Channel
    • 6.3.6. By Region

7. North America Dry Eye Syndrome Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Indication
    • 7.2.2. By Product Type
    • 7.2.3. By Dosage Form
    • 7.2.4. By Type
    • 7.2.5. By Distribution Channel
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Dry Eye Syndrome Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Indication
        • 7.3.1.2.2. By Product Type
        • 7.3.1.2.3. By Dosage Form
        • 7.3.1.2.4. By Type
        • 7.3.1.2.5. By Distribution Channel
    • 7.3.2. Canada Dry Eye Syndrome Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Indication
        • 7.3.2.2.2. By Product Type
        • 7.3.2.2.3. By Dosage Form
        • 7.3.2.2.4. By Type
        • 7.3.2.2.5. By Distribution Channel
    • 7.3.3. Mexico Dry Eye Syndrome Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Indication
        • 7.3.3.2.2. By Product Type
        • 7.3.3.2.3. By Dosage Form
        • 7.3.3.2.4. By Type
        • 7.3.3.2.5. By Distribution Channel

8. Europe Dry Eye Syndrome Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Indication
    • 8.2.2. By Product Type
    • 8.2.3. By Dosage Form
    • 8.2.4. By Type
    • 8.2.5. By Distribution Channel
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Dry Eye Syndrome Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Indication
        • 8.3.1.2.2. By Product Type
        • 8.3.1.2.3. By Dosage Form
        • 8.3.1.2.4. By Type
        • 8.3.1.2.5. By Distribution Channel
    • 8.3.2. Germany Dry Eye Syndrome Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Indication
        • 8.3.2.2.2. By Product Type
        • 8.3.2.2.3. By Dosage Form
        • 8.3.2.2.4. By Type
        • 8.3.2.2.5. By Distribution Channel
    • 8.3.3. United Kingdom Dry Eye Syndrome Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Indication
        • 8.3.3.2.2. By Product Type
        • 8.3.3.2.3. By Dosage Form
        • 8.3.3.2.4. By Type
        • 8.3.3.2.5. By Distribution Channel
    • 8.3.4. Italy Dry Eye Syndrome Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Indication
        • 8.3.4.2.2. By Product Type
        • 8.3.4.2.3. By Dosage Form
        • 8.3.4.2.4. By Type
        • 8.3.4.2.5. By Distribution Channel
    • 8.3.5. Spain Dry Eye Syndrome Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Indication
        • 8.3.5.2.2. By Product Type
        • 8.3.5.2.3. By Dosage Form
        • 8.3.5.2.4. By Type
        • 8.3.5.2.5. By Distribution Channel

9. Asia-Pacific Dry Eye Syndrome Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Indication
    • 9.2.2. By Product Type
    • 9.2.3. By Dosage Form
    • 9.2.4. By Type
    • 9.2.5. By Distribution Channel
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Dry Eye Syndrome Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Indication
        • 9.3.1.2.2. By Product Type
        • 9.3.1.2.3. By Dosage Form
        • 9.3.1.2.4. By Type
        • 9.3.1.2.5. By Distribution Channel
    • 9.3.2. India Dry Eye Syndrome Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Indication
        • 9.3.2.2.2. By Product Type
        • 9.3.2.2.3. By Dosage Form
        • 9.3.2.2.4. By Type
        • 9.3.2.2.5. By Distribution Channel
    • 9.3.3. Japan Dry Eye Syndrome Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Indication
        • 9.3.3.2.2. By Product Type
        • 9.3.3.2.3. By Dosage Form
        • 9.3.3.2.4. By Type
        • 9.3.3.2.5. By Distribution Channel
    • 9.3.4. South Korea Dry Eye Syndrome Treatment Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Indication
        • 9.3.4.2.2. By Product Type
        • 9.3.4.2.3. By Dosage Form
        • 9.3.4.2.4. By Type
        • 9.3.4.2.5. By Distribution Channel
    • 9.3.5. Australia Dry Eye Syndrome Treatment Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Indication
        • 9.3.5.2.2. By Product Type
        • 9.3.5.2.3. By Dosage Form
        • 9.3.5.2.4. By Type
        • 9.3.5.2.5. By Distribution Channel

10. South America Dry Eye Syndrome Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Indication
    • 10.2.2. By Product Type
    • 10.2.3. By Dosage Form
    • 10.2.4. By Type
    • 10.2.5. By Distribution Channel
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Dry Eye Syndrome Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Indication
        • 10.3.1.2.2. By Product Type
        • 10.3.1.2.3. By Dosage Form
        • 10.3.1.2.4. By Type
        • 10.3.1.2.5. By Distribution Channel
    • 10.3.2. Argentina Dry Eye Syndrome Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Indication
        • 10.3.2.2.2. By Product Type
        • 10.3.2.2.3. By Dosage Form
        • 10.3.2.2.4. By Type
        • 10.3.2.2.5. By Distribution Channel
    • 10.3.3. Colombia Dry Eye Syndrome Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Indication
        • 10.3.3.2.2. By Product Type
        • 10.3.3.2.3. By Dosage Form
        • 10.3.3.2.4. By Type
        • 10.3.3.2.5. By Distribution Channel

11. Middle East and Africa Dry Eye Syndrome Treatment Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Indication
    • 11.2.2. By Product Type
    • 11.2.3. By Dosage Form
    • 11.2.4. By Type
    • 11.2.5. By Distribution Channel
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Dry Eye Syndrome Treatment Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Indication
        • 11.3.1.2.2. By Product Type
        • 11.3.1.2.3. By Dosage Form
        • 11.3.1.2.4. By Type
        • 11.3.1.2.5. By Distribution Channel
    • 11.3.2. Saudi Arabia Dry Eye Syndrome Treatment Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Indication
        • 11.3.2.2.2. By Product Type
        • 11.3.2.2.3. By Dosage Form
        • 11.3.2.2.4. By Type
        • 11.3.2.2.5. By Distribution Channel
    • 11.3.3. UAE Dry Eye Syndrome Treatment Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Indication
        • 11.3.3.2.2. By Product Type
        • 11.3.3.2.3. By Dosage Form
        • 11.3.3.2.4. By Type
        • 11.3.3.2.5. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Developments
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Launches

14. Global Dry Eye Syndrome Treatment Market: SWOT Analysis

15. Porters Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products/Services

16. Competitive Landscape

  • 16.1. Johnson & Johnson Services, Inc.
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. AbbVie Inc.
  • 16.3. Bausch Health Companies Inc.
  • 16.4. Novartis AG
  • 16.5. Sun Pharmaceuticals Industries Limited
  • 16.6. Santen Pharmaceutical Co., Ltd.
  • 16.7. Otsuka Pharmaceutical Co., Ltd.
  • 16.8. Oyster Point Pharma, Inc.
  • 16.9. Alcon Inc.
  • 16.10. GlaxoSmithKline plc

17. Strategic Recommendations

18. About Us & Disclaimer